Histamine H1 receptors and affinity analyses in human nasal mucosa in cases of nasal allergy. 1985

T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa

An increased number (density) or sensitivity (affinity) of histamine H1 receptors could cause an increase of allergic symptoms. Using the specific H1 receptor blocker 3H-mepyramine, we have demonstrated for the first time an H1 receptor number (Bmax) and a binding affinity (Kd) in guinea pig and human nasal mucosa. H1 antihistamines inhibited that 3H-mepyramine binding sites represent H1 receptors in nasal mucosa. Bmax and Kd values were not significantly different among the nonallergic sinusitis, vasomotor rhinitis, or the nasal allergy group, suggesting that H1 receptors do not change quantitatively and qualitatively in allergic nasal mucosa. There was no significant correlation between H1 receptor number and clinical data (IgE, peripheral eosinophils, RAST). These data suggest that H1 receptor number and affinity are not main etiological and pathophysiological factors in nasal allergy.

UI MeSH Term Description Entries
D008297 Male Males
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D011738 Pyrilamine A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies. Mepyramine,Pyranisamine,Anthisan,Boots Bite & Sting Relief,Kriptin,Mepyramine Maleate,Pyrilamine Maleate,Maleate, Mepyramine,Maleate, Pyrilamine
D011968 Receptors, Histamine Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action. Histamine Binding Sites,Histamine Receptors,Histamine Receptor,Binding Sites, Histamine,Receptor, Histamine,Sites, Histamine Binding
D011969 Receptors, Histamine H1 A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (From Biochem Soc Trans 1992 Feb;20(1):122-5) H1 Receptor,Histamine H1 Receptors,H1 Receptors,Histamine H1 Receptor,Receptors, H1,H1 Receptor, Histamine,H1 Receptors, Histamine,Receptor, H1,Receptor, Histamine H1
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
January 1999, Acta oto-laryngologica,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
April 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
January 1985, Acta oto-laryngologica,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
January 1983, Archives of oto-rhino-laryngology,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
June 1992, The Journal of allergy and clinical immunology,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
April 1985, Agents and actions,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
January 2004, European journal of pharmacology,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
July 1999, Auris, nasus, larynx,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
April 1979, Agents and actions,
T Ishibe, and N Kubo, and H Kumazawa, and T Yamashita, and T Kamazawa
March 1982, European journal of pharmacology,
Copied contents to your clipboard!